UBS Group »

Virpax Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Virpax Pharmaceuticals shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Virpax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Virpax Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Virpax Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1k 6.6k 0.32
2023-09-30 $93 118 0.80
2022-12-31 $7.3k 12k 0.62
2022-09-30 $7.0k 6.3k 1.11
2021-12-31 $39k 11k 3.43
2021-06-30 $18k 3.9k 4.57
2021-03-31 $14k 3.0k 4.70